In re GLP-1 RA Products Liability Litigation. Represents Eli Lilly in federal MDL and related state court litigation involving alleged failure to warn of certain gastrointestinal and vision risks.
DePaul et al. v. Kimberly-Clark Corp. Represents Kimberly-Clark in toxic tort matter including winning a full dismissal of a federal court case on the merits. See “Litigator of the (Past) Week Runners-Up and Shout-Outs” The Am Law Litigation Daily, April 7, 2026.
In re HIV Antitrust Litigation. Represented Gilead Sciences in antitrust class actions brought by direct and indirect purchasers of HIV drugs. After a six-week trial, the jury returned a complete defense verdict, rejecting plaintiffs’ pay-for-delay claims, for which they sought over $10 billion in compensatory and treble damages. See “How A 3-Firm 'Joint Effort' Beat A $3.6B Pharma Antitrust Suit” Law360, July 5, 2023.
In re Juul Labs Marketing & Products Liability Litigation. Represented JLI in MDL and related state cases brought by Attorney Generals alleging personal injury, economic damages and public nuisance related to e-cigarette product and marketing.
Zurich Am. Ins. Co. et al. v. Hardin, III et al. Represented Zurich in a federal court alter ego action. After a week trial, the jury returned an $18 million verdict in favor of the insurer.*
*Prior to joining Kirkland
